Diisocyanates, occupational asthma and IgE antibody: Implications for hazard characterization

Journal of Applied Toxicology

Volumn 34, Issue 10, 2014, Pages 1073-1077

  Kimber, Ian ^a   Dearman, Rebecca J ^a   Basketter, David A ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b DABMEB CONSULTANCY LTD   (United Kingdom)

Author keywords

Chemical respiratory allergy; Diisocyanate; Hazard characterization; IgE antibody; Occupational asthma

Indexed keywords

ALLERGEN; DIPHENYLMETHANE 4,4' DIISOCYANATE; HEXAMETHYLENE DIISOCYANATE; IMMUNOGLOBULIN E ANTIBODY; ISOCYANIC ACID DERIVATIVE; TOLUENE DIISOCYANATE; AIR POLLUTANT; IMMUNOGLOBULIN E;

ANTIBODY RESPONSE; ARTICLE; FATALITY; HUMAN; IMMUNE RESPONSE; MORBIDITY; NONHUMAN; OCCUPATIONAL ASTHMA; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SENSITIZATION; AIR POLLUTANT; CHEMICALLY INDUCED; IMMUNOLOGY; PATHOPHYSIOLOGY; RESPIRATORY HYPERSENSITIVITY;

AIR POLLUTANTS, OCCUPATIONAL; ALLERGENS; ASTHMA, OCCUPATIONAL; HUMANS; IMMUNOGLOBULIN E; ISOCYANATES; RESPIRATORY HYPERSENSITIVITY;

EID: 84904994163     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3041     Document Type: Article

References (56)

1. Bakerly ND, Moore VC, Vellore AD, Jaakkola MS, Robertson AS, Burge PS. 2008. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup. Med. 58: 169-174.
2. Basketter DA, Kimber I. 2011. Assessing the potency of respiratory allergens: uncertainties and challenges. Reg. Toxicol. Pharmacol. 61: 365-372.
3. Baur X. 2013. A compendium of causative agents of occupational asthma. J. Occup. Med. Toxicol. 8: 1-8.
4. Baur X, Bakehe P. 2014. Allergens causing occupational asthma: an evidence-based evaluation of the literature. Int. Arch. Occup. Environ. Health 87: 339-363.
5. Bentley, AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, Jeffrey PK, Durham SR, Kay AB. 1992. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J. Allergy Clin. Immunol. 89: 821-829.
6. Boverhof DR, Billington R, Gollapudi BB, Hotchkiss JR, Krieger SM, Poole A, Wiecinski CM, Woolhiser MR. 2008. Respiratory sensitisation and allergy. Current research approaches and needs. Toxicol. Appl. Pharmacol. 226: 1-13.
7. Budnik LT, Preisser AM, Permentier H, Baur X. 2013. Is specific IgE antibody analysis feasible for diagnosis of methylenediphenyl diisocyanate-induced occupational asthma? Int. Arch. Occup. Environ. Health 86: 417-430.
8. Campo R, Wisnewski AV, Lummus Z, Cartier A, Malo J-L, Boulet LP, Bernstein DI. 2007. Diisocyanate conjugate and immunoassay characteristics influence detection of specific antibodies in HDI-exposed workers. Clin. Exp. Allergy 37: 1095-1102.
9. Cartier A, Grammer LC, Malo J-L, Lagier F, Ghezzo H, Harris K, Patterson R. 1989. Specific serum antibodies against isocyanates. Association with occupational asthma. J. Allergy Clin. Immunol. 84: 507-514.
10. Cullinan P. 1998. Occupational asthma, IgE and IgG. Clin. Exp. Allergy 28: 688-690.
11. Dearman RJ, Betts CJ, Humphreys N, Flanagan BF, Gilmour NJ, Basketter DA, Kimber I. 2003. Chemical allergy: considerations for the practical application of cytokine profiling. Toxicol. Sci. 71: 137-145.
12. De Jong WH, Arts JH, De Klerk A, Schijf MA, Kuper CF, van Loveren H. 2009. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure. Toxicology 261: 103-111.
13. Farraj AK, Harkema JR, Kaminski NE. 2006. Topical application versus intranasal instillation: a quantitative comparison of the effect of the route of sensitization on trimellitic anhydride-induced allergic rhinitis in A/J mice. Toxicol. Sci. 92: 321-328.
14. Fuchs S, Valade P. 1951. Etude Clinique et experimentale suer quelques cas d'intoxication par le desmodur T (diisocyanate de toluylene 1-1-4 et 1-2-6). Arch. Des Maladies Professionelles 12: 191-196.
15. Goutet M, Pepin E, Langonne I, Huguet N, Ban M. 2005. Identification of contact and respiratory sensitizers using flow cytometry. Toxicol. Appl. Pharmacol. 205: 259-270.
16. Hellman L. 2007. Regulation of IgE homeostasis and the identification of potential targets for therapeutic intervention. Biomed. Pharmacother. 61: 34-49.
17. Herrick CA, Das J, Xu L, Wisnewski AV, Redlich CA, Bottomly K. 2003. Differential roles for CD4 and CD8T cells after diisocyanate sensitization: genetic control of TH2-induced lung inflammation. J. Allergy Clin. Immunol. 111: 1087-1094.
18. Hilton J, Dearman RJ, Boylett MS, Fielding I, Basketter DA, Kimber I. 1996. The mouse IgE test for the identification of potential chemical respiratory allergens: considerations of stability and controls. J. Appl. Toxicol. 16: 165-170.
19. Holsapple MP, Jones D, Kawabata TT, Kimber I, Sarlo K, Selgrade MK, Shah J, Woolhiser MR. 2006. Assessing the potential to induce respiratory hypersensitivity. Toxicol. Sci. 91: 4-13.
20. Howe W, Venables KM, Topping MD, Dally MB, Hawkins R, Law SJ, Newman Taylor AJ. 1983. Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody. J. Allergy Clin. Immunol. 71: 5-11.
21. Hur G-Y, Koh D-H, Choi G-S, Park H-J, Choi S-J, Ye Y-M, Kim K-S, Park H-S. 2008. Clinical and immunologic findings of methylene Diphenyl diisocyanate-induced occupational asthma in a car upholstery factor. Clin. Exp. Allergy 38: 586-593.
22. Isola D, Kimber I, Sarlo K, Lalko J, Sipes IG. 2008. Chemical respiratory allergy and occupational asthma: what are the key areas of uncertainty. J. Appl. Toxicol. 28: 249-253.
23. Jones MG, Floyd A, Nouri-Aria KT, Jacobson MR, Durham SR, Newman Taylor A, Cullinan P. 2006. Is occupational asthma to diisocyanates a non-IgE-mediated disease. J. Allergy Clin. Immunol. 117: 663-669.
24. Kenyon NJ, Morrissey BM, Schivo M, Albertson TE. 2012. Occupational asthma. Clin. Rev. Allergy Immunol. 43: 3-13.
25. Kimber I, Basketter DA, Gerberick GF, Ryan CA, Dearman RJ. 2011. Chemical allergy: translating biology into hazard characterization. Toxicol. Sci. 120(Suppl. 1): S238-S268.
26. Kimber I, Dearman RJ. 1997. Cell and molecular biology of chemical allergy. Crit. Rev. Allergy Immunol. 15: 145-168.
27. Kimber I, Dearman RJ. 2002. Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure. Toxicology 181-182: 311-315.
28. Kimber I, Dearman RJ, Basketter DA, Boverhof DR. 2014. Chemical respiratory allergy: reverse engineering an adverse outcome pathway. Toxicology 318: 32-39.
29. Kimber I, Warbrick EV, Dearman RJ. 1998. Chemical respiratory allergy, IgE and the relevance of predictive test methods: a commentary. Hum. Exp. Toxicol. 17: 537-540.
30. Ku H-O, Jeong S-H, Kang H-G, Pyo H-M, Cho J-H, Son S-W, Kim H-R, Lee K-J, Ryu D-Y. 2008. Intracellular expression of cytokines and granzyme B in auricular lymph nodes draining skin exposed to irritants and sensitizers. Toxicology 250: 116-123.
31. Liu Q, Wisnewski AV. 2003. Recent developments in diisocyanate asthma. Ann. Allergy Asthma Immunol. 90: 35-41.
32. Maestrelli P, Occari P, Turato G, Papiris SA, Di Stefano A, Mapp CE, Milani GF, Fabbri LM, Saetta M. 1997. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin. Exp. Allergy 27: 1291-1298.
33. Malo J-L, L'Archeveque JL, Lummus Z, Bernstein D. 2006. Changes in specific IgE and IgG and monocyte chemoattractant protein-1 in workers with occupational asthma caused by diisocyanates and removed from exposure. J. Allergy Clin. Immunol. 118: 530-533.
34. Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. 2005a. Occupational asthma. Am. J. Respir. Crit. Care Med. 172: 280-305.
35. Mapp CE, Boschetto P, Miotto D, De Rosa E. 2005b. Asthma induced by isocyanates: a model of IgE-independent asthma. Acta. Biomed. Suppl. 2: 15-19.
36. Mapp CE, Corona PC, De Marzo N, Fabbri LE. 1988. Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI). Am. Rev. Respir. Dis. 137: 1326-1329.
37. Murdoch RD, Pepys J, Hughes EG. 1986. IgE antibody responses to platinum group metals: a large scale refinery survey. Br. J. Indust. Med. 43: 37-43.
38. Nielsen J, Welinder H, Ottoson H, Bensryd I, Venge P, Skerfving S. 1994. Nasal challenge shows pathogenetic relevance of specific IgE serum antibodies for nasal symptoms caused by hexahydrophthalic anhydride. Clin. Exp. Allergy 24: 440-449.
39. Ott A, Jolly AT, Burkert AL, Brown WE. 2007. Issues in diisocyanate antibody testing. Crit. Rev. Toxicol. 37: 567-585.
40. Ouyang B, Bernstein DI, Lummus ZL, Ying J, Boulet L-P, Cartier A, Gautrin D, Ho S-M. 2013. Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma. Toxicol. Sci. 133: 218-224.
41. Pronk A, Preller L, Raulf-Helmsoth M, Jonkers ICL, Lammers J-W, Woulters IM, Doekes G, Wisnewski AV, Heederik D. 2007. Respiratory symptoms, sensitization and exposure-response relationships in spray painters exposed to isocyanates. Am. J. Respir. Crit. Care Med. 176: 1090-1097.
42. REACH Commission of the European Communities. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off. J. Eur. Union, L396/1 of 30.12. 2006.
43. Redlich CA, Karol MH, Graham C, Homer RJ, Holm CT, Wirth JA, Cullen MR. 1997. Airway isocyanate-adducts in asthma induced by exposure to hexamethylene diisocyanate. Scand. J. Work Environ. Health 23: 227-231.
44. Ross DJ, McDonald JC. 1996. Asthma following inhalation accidents reported to the SWORD project. Ann. Occup. Hyg. 40: 645-650.
45. Saetta M, Di Stefano A, Maestrelli P, De Marzo N, Pivirotto F, Mapp CE, Fabbri LM. 1992. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Ann. Rev. Respir. Dis. 145: 160-168.
46. Sastre J, Vandenplas O, Park H-S. 2003. Pathogenesis of occupational asthma. Eur. Respir. J. 22: 364-373.
47. Tarlo SM. 1999. Diisocyanate sensitization and antibody production. J. Allergy Clin. Immunol. 103: 739-741.
48. Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. 1998. Specific IgE to isocyanates: a useful diagnostic tool in occupational asthma. J. Allergy Clin. Immunol. 101: 709-715.
49. Vandebriel R, Cransveld CC, Crommelin D, Diamant Z, Glazenburg B, Joos G, Kuper F, Natsch A, Nijkamp F, Noteborn H, Pieters R, Roberts D, Roggen E, Rorije E, Seed M, Sewald K, van den Heuvel R, van Engelen J, Verstraelen S, van Loveren, H. 2011. Respiratory sensitization: advances in assessing the risk of respiratory inflammation and irritation. Toxicol. In Vitro 25: 1251-1258.
50. Vandenplas O, Cartier A, Lesage J, Cloutier Y, Perreault G, Grammer LC, Shaugnessy MA, Malo J-L. 1993. Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma. J. Allergy Clin. Immunol. 91: 850-861.
51. Van Och FMM, Van Loveren H, De Jong W, Vandebriel RJ. 2002. Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: an approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol. Appl. Pharmacol. 184: 46-56.
52. Wills-Karp M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Ann. Rev. Immunol. 17: 255-281.
53. Wisnewski AV. 2007. Developments in laboratory diagnostics for isocyanate asthma. Curr. Opinion Allergy Clin. Immunol. 7: 138-145.
54. Wisnewski AV, Jones M. 2010. Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease? Clin. Exp. Allergy 40: 1155-1162.
55. Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chem L, Redlich CA. 2004. Isocyanate vapour-induced antigenicity of human albumin. J. Allergy Clin. Immunol. 113: 1178-1184.
56. Woodbury JW. 1956. Asthmatic syndrome following exposure to tolylene di-isocyanate. Ind. Med. Surg. 25: 540-543.